Ibogaine for Traumatic Brain Injury (TBI): Stanford Study Results
Stanford’s January 2024 study reported improvements in day-to-day functioning, cognition, PTSD, and depression in veterans with treatment-resistant TBI — a population that had failed every conventional treatment.
What did the Stanford study find for ibogaine and TBI?
In 30 special-operations veterans with mostly mild TBI, disability scores fell from 30.2 at baseline to 5.1 one month after a single magnesium–ibogaine treatment, with gains in processing speed and executive function and no decline on any measure. Open-label, no control group.
♥ IBOGAINE FOR TBI
What did the Stanford study find for ibogaine and TBI?
Disability scores fell to non-clinical levels at one month
Stanford’s January 2024 study reported improvements in day-to-day functioning, cognition, PTSD, and depression in veterans with treatment-resistant TBI — a population that had failed every conventional treatment.
baseline to one month
reduction
(all Spec Ops)
events
The Stanford Study: A Breakthrough for TBI Treatment
Published in Nature Medicine (published online 5 January 2024), the study — run by Stanford University School of Medicine with Ambio Life Sciences, Palo Alto University and the VA Palo Alto Health Care System — enrolled 30 US Special Operations veterans — Navy SEALs, Army Rangers, Green Berets — who had sustained multiple traumatic brain injuries and developed treatment-resistant PTSD. Every participant had failed conventional treatments: SSRIs, therapy, VA programs, and other interventions.
Treatment took place at a licensed ibogaine clinic in Mexico under physician supervision with cardiac monitoring. Results were assessed at 1-month follow-up using validated neuropsychological and psychiatric scales.
“MISTIC resulted in significant improvements in functioning both immediately and 1 month after treatment and in PTSD, depression and anxiety at 1 month after treatment. There were no unexpected or serious adverse events. Controlled clinical trials to assess safety and efficacy are needed to validate these initial open-label findings.”
Cherian KN, Keynan JN, et al., Nature Medicine 2024;30(2):373–381 — observational, open-label, no control group
Why Ibogaine May Help TBI Where Other Treatments Fail
Neuroinflammation Reduction via Sigma-1 Receptors
TBI causes chronic neuroinflammation that persists for years. Ibogaine acts as a sigma-1 receptor agonist, which has known anti-inflammatory effects on the central nervous system — reducing the ongoing inflammatory cascade that perpetuates TBI symptoms.
GDNF and BDNF — Neural Repair Factors
Ibogaine triggers significant upregulation of GDNF (glial cell line-derived neurotrophic factor) and BDNF (brain-derived neurotrophic factor). These are the brain’s primary repair molecules — they promote neurogenesis, synaptic plasticity, and the repair of damaged neural circuits.
Neuroplasticity Window
Ibogaine opens a prolonged period of enhanced neuroplasticity — the brain’s ability to reorganize and form new connections. For TBI patients, this window may allow the brain to recruit compensatory pathways and begin functional recovery that was previously impossible.
Trauma Processing — The Co-Occurring PTSD Problem
In veterans especially, TBI and PTSD are deeply intertwined — the trauma that caused the injury also leaves psychological wounds. Ibogaine addresses both simultaneously: the neurological damage through its pharmacology, and the psychological trauma through the psychedelic experience itself.
Who Is a Candidate for Ibogaine TBI Treatment?
The Stanford study specifically enrolled patients with treatment-resistant conditions — meaning ibogaine may be most valuable when conventional approaches have not worked. Ideal candidates include:
✓
Veterans with combat-related TBI who have not responded to VA treatment programs
✓
Athletes with concussion history and post-concussion syndrome (CTE risk)
✓
First responders (police, firefighters, EMTs) with occupational TBI
✓
Patients with TBI who also have concurrent PTSD, depression, or substance use disorder
✓
Anyone with cognitive symptoms (memory, focus, executive function) following brain injury
Veteran Resources
Veterans facing financial barriers to ibogaine treatment may be eligible for grants and scholarships from:
Heroic Hearts Project (heroicheartsproject.org) — provides grants for veterans seeking psychedelic-assisted therapy
VETS (Veterans Exploring Treatment Solutions) — veteran-focused psychedelic therapy organization
2024 Executive Order — directed VA and DoD to fast-track ibogaine research for veterans
Ready to Explore Ibogaine for TBI?
We specialize in connecting veterans and TBI patients with clinics that have experience with neurological and trauma applications. Consultation — no pressure.
Related on this site: ibogaine for veterans · veterans with TBI · Parkinson's and neurological conditions · ibogaine safety guide · what treatment costs
Sources and further reading
- Nature Medicine (2024): magnesium–ibogaine therapy in veterans with traumatic brain injury — open-label, n=30, no control group
- SAMHSA National Helpline (1-800-662-HELP) — free, confidential, 24/7
Speak with an advisor.
A confidential conversation about your situation and the options actually worth considering — from people who visit every provider they recommend.